PFE Pfizer Inc

  1. Stocks
  2. Healthcare
  3. NYSE: PFE

Price (delayed)

$30.055

Market cap

$171.3B

P/E Ratio

39.55

Dividend/share

$1.72

EPS

$0.76

Enterprise value

$233.52B

?
Relative Growth: Rel. Growth: 10
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 32
Relative Profitability: Rel. Profitability: 46

At Pfizer Oncology, we are at the forefront of a new era in cancer care. Our industry-leading portfolio and extensive pipeline includes three core mechanisms of action to attack cancer ...

Highlights
The quick ratio has grown by 10% YoY
The price to earnings (P/E) is 101% higher than the 5-year quarterly average of 19.9 and 90% higher than the last 4 quarters average of 21.1
Pfizer's EPS has plunged by 60% YoY and by 42% from the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - General
Website: http://www.pfizer.com
Peers: MRK JNJ BMY LLY

Key stats

What are the main financial stats of PFE

PFE stock price

How has the Pfizer stock price performed over time
Intraday
-1.2%
1 week
1.61%
1 month
6.65%
1 year
21.83%
YTD
20.7%
QTD
5.38%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$63.7B
Gross profit
$46.61B
Operating income
$4.21B
Net income
$4.33B
Gross margin
73.2%
Net margin
6.8%
The company's operating margin has shrunk by 60% YoY and by 47% QoQ
Pfizer's net income has shrunk by 60% YoY and by 42% QoQ
PFE's net margin has plunged by 60% YoY and by 42% from the previous quarter
The operating income has plunged by 60% YoY and by 47% from the previous quarter

Price vs fundamentals

How does PFE's price correlate with its fundamentals

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
PFE P/E details
P/E
39.55
P/B
2.01
P/S
2.69
EV/EBIT
56
EV/EBITDA
21.71
EV/Sales
3.67
The price to earnings (P/E) is 101% higher than the 5-year quarterly average of 19.9 and 90% higher than the last 4 quarters average of 21.1
Pfizer's EPS has plunged by 60% YoY and by 42% from the previous quarter
PFE's P/B is 28% above its last 4 quarters average of 1.6 but 7% below its 5-year quarterly average of 2.2
Pfizer's equity has decreased by 5% QoQ and by 4% YoY
PFE's P/S is 18% above its last 4 quarters average of 2.3 and 4.6% above its 5-year quarterly average of 2.6

Efficiency

How efficient is Pfizer business performance
Pfizer's ROS has plunged by 61% YoY and by 48% from the previous quarter
The company's return on invested capital has shrunk by 61% YoY and by 48% QoQ
The ROE has shrunk by 59% YoY and by 42% QoQ
Pfizer's ROA has plunged by 59% YoY and by 42% from the previous quarter

Dividends

What is PFE's dividend history
Dividend details
DPS
$1.72
Dividend yield
5.72%
Payout ratio
226.3%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Pfizer financials performed over time
PFE's total assets is 74% greater than its total liabilities
The quick ratio has grown by 10% YoY
The current ratio has grown by 9% YoY
PFE's debt is 26% less than its equity
The debt to equity has grown by 6% YoY and by 2.8% from the previous quarter
Pfizer's equity has decreased by 5% QoQ and by 4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.